New insights into prevalence and risk factors of anemia among women of reproductive age in China

Anemia significantly impacts global public health, with over 571 million women at risk of adverse health outcomes due to iron deficiency and other causes.

Revolution sells $600M in shares on back of RAS inhibitor portfolio updates

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 4, 2024

Bristol Myers wins approval for KRAS drug Krazati in colorectal cancer

Bristol Myers Squibb won accelerated approval on Friday to take its KRAS inhibitor to colorectal cancer patients. Krazati will now be available for use with

June 22, 2024

Workplace Collaboration Linked to Positive Employee Mental Health

What You Should Know: TELUS Health today released its monthly Mental Health Index which revealed that workers who collaborate with others in the workplace have

June 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.